Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile
General Stock Board Listed Company Profile
Local/Foreign Company:
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Yi-Ning Su CHIA-CHENG HUNG CHIA-CHENG HUNG (02)2382 6615 4F.-2, No. 66-1, Sec. 1, Chongqing S. Rd., Zhongzheng Dist.,Taipei City 100, Taiwan (R.O.C.) 2018/01/22
Industry Main Business
Biotechnology and Medical Care
Our medical laboratory at Sofiva Genomics is led by an integrated team of R&D professionals, lab technicians, bioinformatics analysts, database specialists, and clinicians, all working together to promote clinical research and application of genomics within the context of preventative medicine. Our gifted team of R&D and technical specialists are at the forefront, both locally and internationally, of developing diagnostic platforms to read genes associated with spinal muscular atrophy, neonatal sensorineural hearing loss, and congenital central hypoventilation syndrome. Their work also includes testing gene array and conducting preimplantation genetic diagnosis, NGS for PGS, and NIPS+. We have developed customized genetic testing services that allow us to predict and sometimes take early preventative measures against certain health conditions.
Market Information ( 2021/04/16 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
48.22 55.50  53.20  55.00  1.80  47 0.22 N/A N/A
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.